Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CervoMed (CRVO) Return on Equity (2022 - 2025)

CervoMed (CRVO) has disclosed Return on Equity for 8 consecutive years, with 1.22% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 83.0% to 1.22% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.22% through Dec 2025, down 83.0% year-over-year, with the annual reading at 0.94% for FY2025, 24.0% down from the prior year.
  • Return on Equity hit 1.22% in Q4 2025 for CervoMed, down from 0.86% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 79.13% in Q2 2022 to a low of 1.22% in Q4 2025.
  • Historically, Return on Equity has averaged 4.75% across 4 years, with a median of 0.2% in 2024.
  • Biggest YoY gain for Return on Equity was 71bps in 2023; the steepest drop was -7886bps in 2023.
  • Year by year, Return on Equity stood at 0.48% in 2022, then crashed by -287bps to 0.9% in 2023, then soared by 57bps to 0.38% in 2024, then crashed by -217bps to 1.22% in 2025.
  • Business Quant data shows Return on Equity for CRVO at 1.22% in Q4 2025, 0.86% in Q3 2025, and 0.66% in Q2 2025.